Patents by Inventor Shiqi Ren

Shiqi Ren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9840551
    Abstract: The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodies which specifically recognize the epitopes. The present invention also provides methods for the early screen, diagnosis or prognosis of epithelium derived cancers in subjects, methods for the evaluation of therapeutic effect of related medicaments or therapies, and kits for accomplishing the methods.
    Type: Grant
    Filed: January 11, 2016
    Date of Patent: December 12, 2017
    Assignee: Beijing Cotimes Biotech Co. Ltd.
    Inventors: Enyun Shen, Yang Song, Shiqi Ren
  • Publication number: 20160122423
    Abstract: The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodies which specifically recognize the epitopes. The present invention also provides methods for the early screen, diagnosis or prognosis of epithelium derived cancers in subjects, methods for the evaluation of therapeutic effect of related medicaments or therapies, and kits for accomplishing the methods.
    Type: Application
    Filed: January 11, 2016
    Publication date: May 5, 2016
    Inventors: Enyun SHEN, Yang Song, Shiqi Ren
  • Patent number: 9290564
    Abstract: The present disclosure relates generally to anti-rabies antibodies that can bind to and neutralize rabies virus. Antibodies of the present technology are useful alone or in combination with therapies known in the art for the treatment or prevention of rabies infection.
    Type: Grant
    Filed: May 24, 2012
    Date of Patent: March 22, 2016
    Assignee: MOUNTGATE GROUP LIMITED
    Inventors: Enyun Shen, Shiqi Ren
  • Patent number: 9255142
    Abstract: The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides cancer-related epitopes of cytokeratins and monoclonal antibodies which specifically recognize the epitopes. The present invention also provides methods for the early screen, diagnosis or prognosis of epithelium derived cancers in subjects, methods for the evaluation of therapeutic effect of related medicaments or therapies, and kits for accomplishing the methods.
    Type: Grant
    Filed: September 9, 2010
    Date of Patent: February 9, 2016
    Assignee: BEIJING COTIMES BIOTECH CO., LTD.
    Inventors: Enyun Shen, Yang Song, Shiqi Ren
  • Publication number: 20150110781
    Abstract: The present disclosure relates generally to anti-rabies antibodies that can bind to and neutralize rabies virus. Antibodies of the present technology are useful alone or in combination with therapies known in the art for the treatment or prevention of rabies infection.
    Type: Application
    Filed: May 24, 2012
    Publication date: April 23, 2015
    Inventors: Enyun Shen, Shiqi Ren
  • Publication number: 20130260388
    Abstract: The present invention provides uses of cytokeratins as markers for diagnosing epithelium derived cancers. The present invention provides caner-related epitopes of cytokeratins and monoclonal antibodies which specifically recognize the epitopes. The present invention also provides methods for the early screen, diagnosis or prognosis of epithelium derived cancers in subjects, methods for the evaluation of therapeutic effect of related medicaments or therapies, and kits for accomplishing the methods.
    Type: Application
    Filed: September 9, 2010
    Publication date: October 3, 2013
    Inventors: Enyun Shen, Yang Song, Shiqi Ren